New Insights into Bioactive Compounds of Traditional Chinese Medicines for Insulin Resistance Based on Signaling Pathways.
Jian HeHui WangJan VijgPublished in: Chemistry & biodiversity (2019)
Type 2 diabetes is a serious metabolic disease as a long-term threat to human health. Insulin resistance is not only the basis and major feature of type 2 diabetes, but also the main etiology of diseases such as hypertension, hyperlipidemia and coronary heart disease. It has been shown that Traditional Chinese Medicines (TCMs) play an important role in the treatment of type 2 diabetes, through attenuating insulin resistance, whereas the mechanism involved is not yet well understood. Therefore, it is important to elucidate the pharmacological mechanism of these bioactive compounds so that one can pave the way for the modernization of TCMs. In this review, we focus on the recent progresses of some bioactive ingredients from TCMs with different functional groups, which exhibit therapeutic potential for the treatment of diabetic insulin resistance. It is expected that this review can provide new references for developing TCM-derived drugs against diabetes and insulin resistance in the future.
Keyphrases
- insulin resistance
- type diabetes
- high fat diet
- glycemic control
- adipose tissue
- human health
- metabolic syndrome
- high fat diet induced
- polycystic ovary syndrome
- skeletal muscle
- risk assessment
- cardiovascular disease
- signaling pathway
- blood pressure
- machine learning
- climate change
- induced apoptosis
- oxidative stress
- replacement therapy
- smoking cessation
- cell proliferation
- endoplasmic reticulum stress
- arterial hypertension